<DOC>
	<DOCNO>NCT00882011</DOCNO>
	<brief_summary>The purpose study create prospective database T-Lymphoblastic Lymphoma ( T-LBL ) case order conduct appropriate statistical study well monitor diagnosis minimal residual disease ( MRD ) , detect specific genetic profile useful give advice therapy , assess PET prognostic validity T-Lymphoblastic Lymphoma ( T-LBL ) .</brief_summary>
	<brief_title>Observational Controlled Clinical Trials , Adult Patients With T-lymphoblastic Lymphoma Treated With Intensive Chemo/Radiotherapy Intensive Chemotherapy Followed Transplant . Evaluation Clinical , Anatomy -Pathological Parameters</brief_title>
	<detailed_description>Observational prospective Clinical Trial design : - record patient treat late generation ALL-like therapy ( e.g . : Holzer , LSA2-L2 modify , GIMEMA LAL094 ) , enhance therapy ( hyper-CVAD Stanford ) , autologous allogeneic transplant reduce intensity conditioning allotransplant induction/consolidation also expect case treat high dose sequential therapy intensify minimal residual disease ( MRD ) orient therapy ; - enter classic T-LBL patient ( bone marrow infiltrate &lt; 25 % ) treat long previous section ; - monitor therapy response/phenotype ratio study phenotype ; - monitor therapy response/residual disease/patients outcome ratio study T-cell receptor gene rearrangement ; - evaluate gene-profile difference T-LBL pre-thymic phenotype T-LBL thymic phenotype correlate outcome ; - monitor stage disease diagnosis , therapy follow-up mean TAC , value PET ( association TAC ) additional and/or outcome predict element compare TAC .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<criteria>previous therapy , except treatment face clinical presentation emergency ; medical history initially characterize nodal mass/masses ; histological immunophenotypic diagnosis document diagnosis TLBL ; case bone marrow involvement difficulty obtain nodal material , diagnosis could base bone marrow ; availability biological material study TCR geneprofile ; age â‰¥ 15 year ; stage ; infiltrate bone marrow &lt; 25 % ; normal liver , renal cardiac function , except alteration directly relate lymphoma ; estimate treatment accord one last generation schedule ; write informed consent . patient previous HCV , HBsAg+ suffer HIV ; patient organic pathology relate lymphoma .</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>T-lymphoblastic lymphoma</keyword>
	<keyword>Intensive chemo/radiotherapy</keyword>
	<keyword>Intensive chemotherapy</keyword>
	<keyword>Transplant</keyword>
	<keyword>Adult patient</keyword>
</DOC>